NCT06298331 Investigation of the Additional Effects of Aerobic Exercise Training to Abdominal Massage in Functional Constipation
| NCT ID | NCT06298331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Constipation |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-03-15 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-03-15 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to investigate the additional effects of aerobic exercise to abdominal massage in patients with functional constipation. There are several studies investigating the effects of massage and aerobic exercise separately in functional constipation. However, to the best of our knowledge, there are no studies combining abdominal massage and aerobic exercise to demonstrate additional effects. By combining these two approaches, we believe that a higher and broader effect (local and systemic) and perhaps a cure for constipation (reaching the ideal defecation frequency or asymptomatic status) can be achieved. Therefore, this study will include individuals between the ages of 18-65 who have a diagnosis of functional constipation and who agree to participate in the study. This study is designed as a randomized controlled trial.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 18-65 * Diagnosed with chronic constipation according to Rome IV criteria * No new treatment for constipation in the last 3 months * Absence of any condition that would prevent compliance with the interventions and assessments in the study Exclusion Criteria: * Presence of secondary constipation ( uncontrolled metabolic disease (uncontrolled DM, hypothyroidism), hyperparathyroidism, neurologic disease or use of anticoagulants, anticholinergics, antihistamines, antipsychotics or opioids) * In individuals over 50 years of age, the presence of alarm symptoms (new-onset constipation, rectal bleeding, involuntary weight loss, nausea and vomiting, fever and anemia) * having BMI \> 30 kg/m² * having cancer diagnosis * being pregnant or breastfeeding, being within the first year postnatally * having irritable Bowel Syndrome, Hirschprung's Disease, Crohn's Disease, Inflammatory Bowel Disease, Megacolon diagnosis, Megarectum diagnosis, Rectocele and enterocele stage 3 and above * presence of advanced systemic disease (e.g. cardiovascular, respiratory, renal or hepatic diseases) * history of abdomino-pelvic or gastrointestinal surgery in the last 6 months * presence of open wound, disruption of skin integrity, local tumor, cholestomy or abdominal hernia at the massage site * Presence of orthopedic (e.g. lumbopelvic pain, advanced knee joint degeneration) and cardiovascular diseases (e.g. acute coronary syndrome, stage 3-4 heart valve diseases) that may prevent aerobic exercise training
Contact & Investigator
Serap ÖZGÜL, Prof
PRINCIPAL INVESTIGATOR
Hacettepe University, Department of Physiotherapy and Rehabilitation
Frequently Asked Questions
Who can join the NCT06298331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Constipation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06298331 currently recruiting?
Yes, NCT06298331 is actively recruiting participants. Contact the research team at serapky@yahoo.com for enrollment information.
Where is the NCT06298331 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06298331 clinical trial?
NCT06298331 is sponsored by Hacettepe University. The principal investigator is Serap ÖZGÜL, Prof at Hacettepe University, Department of Physiotherapy and Rehabilitation. The trial plans to enroll 44 participants.